INSMED INC (INSM)

1 Vanguard Index Fund May Beat the S&P 500 by 100% in the Next Few Years, According to a Wall Street Analyst

Notable Monday Option Activity: INSM, MARA, ALGM

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...

Insmed To Present at November 2024 Investor Conferences

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...

Notable Thursday Option Activity: LPLA, INSM, BMY

Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update

—ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $93.4 Million for the Third Quarter of 2024, Reflecting 18% Growth Over the Third Quarter...

Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...

Insmed Unites Across Communities Around the World During Third Annual Global Day of Good

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...

Notable Friday Option Activity: INSM, ORA, BPMC

Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...

New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...

Insmed Moves Up In Market Cap Rank, Passing Camden Property Trust

Meta Stock Leads 5 Names Near Buy Points As Market Bounces

The major indexes rose strongly Friday on Fed Chair Jerome Powell's speech.

Notable Friday Option Activity: DECK, TTWO, INSM

INSM Stock Earnings: Insmed Misses EPS, Beats Revenue for Q2 2024

INSM stock results show that Insmed missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update

—ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $90.3 Million for the Second Quarter of 2024, Reflecting 17% Growth Over the Second...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

A Russell 2000 Bull Market Is Coming: 1 Unstoppable Vanguard ETF to Buy Hand Over Fist

Small-cap stocks are on fire in July, but the Russell 2000 is still in a technical bear market.

Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

1 Historically Cheap Vanguard Index Fund to Buy Before It Soars 40%, According to a Wall Street Analyst

Tom Lee at Fundstrat Global Advisors believes cheap valuations and interest rate cuts will send the Russell 2000 much higher by the end of the summer.

These Signs Show Which Stocks Are Having A Hidden Rally, Says Mark Minervini

Meta stock and Insmed stock share characteristics that can help investors look for strong stocks even in weak markets.